Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Ghys, PD"" wg kryterium: Autor


Tytuł:
Unsafe injections and transmission of HIV-1 in sub-Saharan Africa.
Autorzy:
Gisselquist D (AUTHOR)
Minkin SF (AUTHOR)
Okwuosah A (AUTHOR)
Salerno L (AUTHOR)
Minja-Trupin C (AUTHOR)
Schmid GP (AUTHOR)
Buvé A (AUTHOR)
Calleja JG (AUTHOR)
Ghys PD (AUTHOR)
Boerma JT (AUTHOR)
Bulterys M (AUTHOR)
Chao A (AUTHOR)
Dushimimana A (AUTHOR)
Parekh BS (AUTHOR)
Thoma M (AUTHOR)
Gray RH (AUTHOR)
Kiwanuka N (AUTHOR)
Serwadda D (AUTHOR)
Wawer M (AUTHOR)
Pokaż więcej
Źródło:
Lancet. 5/15/2004, Vol. 363 Issue 9421, p1648-1651. 4p.
URL:
13108522  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
HIV prevention for the next decade: Appropriate, person-centred, prioritised, effective, combination prevention.
Autorzy:
Godfrey-Faussett P; Data for Impact Practice, UNAIDS, Geneva, Switzerland.; London School of Hygiene and Tropical Medicine, London, United Kingdom.
Frescura L; Data for Impact Practice, UNAIDS, Geneva, Switzerland.
Abdool Karim Q; CAPRISA, Durban, South Africa.
Clayton M; Independent Consultant, Windhoek, Namibia.
Ghys PD; Data for Impact Practice, UNAIDS, Geneva, Switzerland.
Pokaż więcej
Corporate Authors:
(on behalf of the 2025 prevention targets working group)
Źródło:
PLoS medicine [PLoS Med] 2022 Sep 26; Vol. 19 (9), pp. e1004102. Date of Electronic Publication: 2022 Sep 26 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Acquired Immunodeficiency Syndrome*/epidemiology
Epidemics*
HIV Infections*/epidemiology
HIV Infections*/prevention & control
Humans ; Incidence
Czasopismo naukowe
Tytuł:
Achieving the 95 95 95 targets for all: A pathway to ending AIDS.
Autorzy:
Frescura L; Strategic Information Department, UNAIDS, Geneva, Switzerland.
Godfrey-Faussett P; Strategic Information Department, UNAIDS, Geneva, Switzerland.; London School of Hygiene and Tropical Medicine, London, United Kingdom.
Feizzadeh A A; Strategic Information Department, UNAIDS, Geneva, Switzerland.
El-Sadr W; ICAP at Columbia University, Mailman School of Public Health, New York, New York, United States of America.
Syarif O; Global Network of People Network Living with HIV (GNP+), Gardens, South Africa.
Ghys PD; Strategic Information Department, UNAIDS, Geneva, Switzerland.
Pokaż więcej
Corporate Authors:
on and behalf of the 2025 testing treatment target Working Group
Źródło:
PloS one [PLoS One] 2022 Aug 04; Vol. 17 (8), pp. e0272405. Date of Electronic Publication: 2022 Aug 04 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Acquired Immunodeficiency Syndrome*/drug therapy
Acquired Immunodeficiency Syndrome*/epidemiology
Acquired Immunodeficiency Syndrome*/prevention & control
HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV Infections*/prevention & control
HIV Testing ; Humans ; Incidence ; United Nations
Czasopismo naukowe
Tytuł:
Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030.
Autorzy:
Stover J; Avenir Health, Glastonbury, Connecticut, United States of America.
Glaubius R; Avenir Health, Glastonbury, Connecticut, United States of America.
Teng Y; Avenir Health, Glastonbury, Connecticut, United States of America.
Kelly S; Burnet Institute, Melbourne, Victoria, Australia.
Brown T; East-West Center, Honolulu, Hawaii, United States of America.
Hallett TB; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, United Kingdom.
Revill P; Centre for Health Economics, University of York, York, United Kingdom.
Bärnighausen T; Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany.
Phillips AN; Institute for Global Health, University College London, London, United Kingdom.
Fontaine C; UNAIDS, Geneva, Switzerland.
Frescura L; UNAIDS, Geneva, Switzerland.
Izazola-Licea JA; UNAIDS, Geneva, Switzerland.
Semini I; UNAIDS, Geneva, Switzerland.
Godfrey-Faussett P; UNAIDS, Geneva, Switzerland.
De Lay PR; Consultant, Washington, DC, United States of America.
Benzaken AS; AIDS Health Care Foundation, Los Angeles, California, United States of America.
Ghys PD; UNAIDS, Geneva, Switzerland.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2021 Oct 18; Vol. 18 (10), pp. e1003831. Date of Electronic Publication: 2021 Oct 18 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Disease Eradication*
Global Health*
Goals*
Models, Biological*
Models, Theoretical*
Public Health*
HIV Infections/*prevention & control
Acquired Immunodeficiency Syndrome/epidemiology ; Acquired Immunodeficiency Syndrome/prevention & control ; Acquired Immunodeficiency Syndrome/therapy ; Adolescent ; Adult ; COVID-19 ; Cause of Death ; Epidemics ; Female ; HIV Infections/epidemiology ; HIV Infections/therapy ; Humans ; Incidence ; Male ; SARS-CoV-2 ; Social Determinants of Health ; United Nations ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies